Dynavax Technologies Corporation is a biopharmaceutical company that develops and sells vaccines, including HEPLISAV-B, a hepatitis B vaccine, and CpG 1018, an adjuvant used in HEPLISAV-B. The company has collaboration and sublicense agreements with other companies and is headquartered in Emeryville, California.